Fascin enhances the vulnerability of breast cancer to erastin-induced ferroptosis
- Cell Death Dis. 2022 Feb 14;13(2):150. doi: 10.1038/s41419-022-04579-1.
- 1. Department of Surgical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- 2. Biomedical Research Center and Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, China.
- 3. Department of Surgical Oncology, Taizhou Hospital, Wenzhou Medical University, Taizhou, China.
- 4. Department of Surgical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. [email protected].
- 5. Biomedical Research Center and Key Laboratory of Biotherapy of Zhejiang Province, Hangzhou, China. [email protected].
- # Contributed equally.
Ferroptosis, which is characterized by intracellular iron accumulation and lipid peroxidation, is a newly described form of regulated cell death that may play a key role in tumour suppression. In the present study, we investigated the expression profiles and biological effects of fascin actin-bundling protein 1 (Fascin, gene name FSCN1) in breast Cancer. In addition, bioinformatics analysis of the TCGA Cancer database and gain- and loss-of-function studies showed that Fascin enhances sensitivity to erastin-induced Ferroptosis. Mechanistically, Fascin directly interacts with cysteine/glutamate transporter (xCT, gene name SLC7A11) and decreases its stability via the ubiquitin-mediated Proteasome degradation pathway. Furthermore, we observed that Fascin is substantially upregulated in tamoxifen-resistant breast Cancer cell lines, and drug-resistant cells were also more vulnerable to erastin-induced Ferroptosis. Taken together, our findings reveal a previously unidentified role of Fascin in Ferroptosis by regulating xCT. Thus, Ferroptosis activation in breast Cancer with high Fascin level may serve as a potential treatment.